| Megan Smith, | |
|
801 5th Ave Se, Devils Lake, ND 58301-3649 | |
| (701) 662-7690 | |
| Not Available |
| Full Name | Megan Smith |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 801 5th Ave Se, Devils Lake, North Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790332773 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 14175190 (North Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Megan Smith, 500 14th Ave Ne Apt 33, Devils Lake, ND 58301-2819 Ph: () - | Megan Smith, 801 5th Ave Se, Devils Lake, ND 58301-3649 Ph: (701) 662-7690 |
News Archive
Kuros Biosurgery AG, a biotechnology company focused on the development of novel biomaterials and bioactive-biomaterial combination products for trauma, wound and spinal indications has signed a license and development agreement with Synthes, Inc. a leading global medical device company.
Faculty from the University of Kentucky Department of Psychology in the College of Arts and Sciences and the Department of Behavioral Science in the College of Medicine have received two, five-year Research Project Grants (R01) from the National Institutes of Health to study neurobehavioral processes involved in drug use disorders.
For a few years now several companies have been marketing "raw water" that has been bottled directly from natural sources such as springs and small water bodies without filtration and treatment.
Sanofi and its subsidiary Genzyme announced today new results from the CARE-MS I trial, the first of two randomized, Phase III clinical trials comparing the investigational drug alemtuzumab to Rebif (high dose subcutaneous interferon beta-1a) in patients with relapsing-remitting multiple sclerosis.
The American College of Medical Genetics issued a position statement to support the use of non-invasive prenatal screening in women with singleton pregnancies.
› Verified 9 days ago
Rachel Marie Quam, MSCCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 412 7th St Ne, Devils Lake, ND 58301 Phone: 701-347-1188 Fax: 701-401-5154 | |
Chase Johnson, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 307 13th Ave Se, Devils Lake, ND 58301 Phone: 701-740-6419 | |
Heidi Grafsgaard, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 801 5th Ave Se, Devils Lake, ND 58301 Phone: 701-662-7690 | |
Speakstrong Therapy, Pllc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 412 7th St Ne, Devils Lake, ND 58301 Phone: 701-347-1188 Fax: 701-402-5154 | |
Mrs. Sheila Halvorson, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 801 5th Ave Se, Devils Lake, ND 58301 Phone: 701-662-7690 Fax: 701-662-7684 | |
Mrs. Stephanie Lin Hodous, MS CCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 801 5th Ave Se, Devils Lake, ND 58301 Phone: 701-662-7690 Fax: 701-662-7684 | |
Mrs. Jennifer L. White, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 801 5th Ave Se, Devils Lake, ND 58301 Phone: 701-662-2769 Fax: 701-662-7684 |